[Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics]

María Vaccarezza1, Walter Silva, Clarisa Maxit

  • 1Servicio de Neuropediatria, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. maria.vaccarezza@hospitalitaliano.org.ar

Revista De Neurologia
|June 22, 2012
PubMed

Insights

The ketogenic diet effectively treated super-refractory status epilepticus in four of five pediatric patients when standard treatments failed. This dietary approach proved safe and beneficial in this severe epilepsy condition.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Metabolic Therapies

Background:

  • Super-refractory status epilepticus (SRSE) is a severe, persistent seizure state unresponsive to standard treatments.
  • Existing pharmacological interventions, including induced coma, often fail to resolve SRSE.
  • The ketogenic diet has been explored as an alternative therapeutic strategy for refractory epilepsy.

Purpose of the Study:

  • To evaluate the efficacy and safety of the ketogenic diet in pediatric patients with SRSE.
  • To assess the ketogenic diet's role when conventional anticonvulsant therapies are ineffective.

Main Methods:

  • Retrospective analysis of five pediatric patients (ages 1-14) with SRSE.
  • Patients included those with febrile infection-related epilepsy syndrome (FIRES) and refractory symptomatic partial epilepsy.
  • All patients underwent multiple prior treatments, including barbiturate-induced coma, before initiating a classical ketogenic diet.

Main Results:

  • The ketogenic diet led to the cessation of clinical and electroencephalographic seizures in four out of five patients.
  • Three patients had FIRES, and two had refractory symptomatic partial epilepsy.
  • The diet was well-tolerated by the responding patients; one patient did not respond and unfortunately died.

Conclusions:

  • The ketogenic diet is a viable and effective therapeutic option for pediatric SRSE when other treatments fail.
  • This dietary intervention demonstrates significant efficacy and a favorable safety profile in managing this critical neurological condition.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...